These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9605377)

  • 1. Near fatal intoxication with controlled-release morphine tablets in a depressed woman.
    Westerling D; Säwe J; Eklundh G
    Acta Anaesthesiol Scand; 1998 May; 42(5):586-9. PubMed ID: 9605377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.
    Quigley C; Joel S; Patel N; Baksh A; Slevin M
    Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients.
    Klepstad P; Dale O; Kaasa S; Zahlsen K; Aamo T; Fayers P; Borchgrevink PC
    Acta Anaesthesiol Scand; 2003 Jul; 47(6):725-31. PubMed ID: 12803591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of the route of administration: a comparative study at steady state of oral sustained release morphine and morphine sulfate suppositories.
    Du X; Skopp G; Aderjan R
    Ther Drug Monit; 1999 Apr; 21(2):208-14. PubMed ID: 10217341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of morphine-6-glucuronide in street heroin addicts.
    Antonilli L; Semeraro F; Suriano C; Signore L; Nencini P
    Psychopharmacology (Berl); 2003 Nov; 170(2):200-4. PubMed ID: 12774191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis.
    Pauli-Magnus C; Hofmann U; Mikus G; Kuhlmann U; Mettang T
    Nephrol Dial Transplant; 1999 Apr; 14(4):903-9. PubMed ID: 10328468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy, safety and pharmacokinetics of a newly developed controlled release morphine sulphate suppository in patients with cancer pain.
    Moolenaar F; Meijler WJ; Frijlink HW; Visser J; Proost JH
    Eur J Clin Pharmacol; 2000 Jun; 56(3):219-23. PubMed ID: 10952476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy.
    Holthe M; Klepstad P; Zahlsen K; Borchgrevink PC; Hagen L; Dale O; Kaasa S; Krokan HE; Skorpen F
    Eur J Clin Pharmacol; 2002 Aug; 58(5):353-6. PubMed ID: 12185559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study.
    Klepstad P; Hilton P; Moen J; Kaasa S; Borchgrevink PC; Zahlsen K; Dale O
    BMC Clin Pharmacol; 2004 Oct; 4():7. PubMed ID: 15461818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine.
    Klepstad P; Kaasa S; Borchgrevink PC
    Eur J Clin Pharmacol; 2000 Jan; 55(10):713-9. PubMed ID: 10663448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose and steady-state kinetics of morphine and its metabolites in cancer patients--a comparison of two oral formulations.
    Hasselström J; Alexander N; Bringel C; Svensson JO; Säwe J
    Eur J Clin Pharmacol; 1991; 40(6):585-91. PubMed ID: 1653145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of oral morphine and its glucuronides in children receiving morphine as immediate-release liquid or sustained-release tablets for cancer pain.
    Hunt A; Joel S; Dick G; Goldman A
    J Pediatr; 1999 Jul; 135(1):47-55. PubMed ID: 10393603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients.
    Klepstad P; Borchgrevink PC; Dale O; Zahlsen K; Aamo T; Fayers P; Fougner B; Kaasa S
    Palliat Med; 2003 Dec; 17(8):679-87. PubMed ID: 14694919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Compartmental Analysis for Morphine and Its Metabolites in Young Children After a Single Oral Dose.
    Velez de Mendizabal N; Jimenez-Mendez R; Cooke E; Montgomery CJ; Dawes J; Rieder MJ; Aleksa K; Koren G; Jacobo-Cabral CO; Gonzalez-Ramirez R; Castañeda-Hernandez G; Carleton BC
    Clin Pharmacokinet; 2015 Oct; 54(10):1083-90. PubMed ID: 25773480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine.
    Somogyi AA; Nation RL; Olweny C; Tsirgiotis P; van Crugten J; Milne RW; Cleary JF; Danz C; Bochner F
    Clin Pharmacokinet; 1993 May; 24(5):413-20. PubMed ID: 8504624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine metabolites.
    Christrup LL
    Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 2):116-22. PubMed ID: 9061094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of renal failure on the disposition of morphine, morphine-3-glucuronide and morphine-6-glucuronide in sheep during intravenous infusion with morphine.
    Milne RW; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
    J Pharmacol Exp Ther; 1997 Aug; 282(2):779-86. PubMed ID: 9262341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative bioavailability of controlled release morphine tablets (MST continus) in cancer patients.
    Poulain P; Hoskin PJ; Hanks GW; A-Omar O; Walker VA; Johnston A; Turner P; Aherne GW
    Br J Anaesth; 1988 Nov; 61(5):569-74. PubMed ID: 3207527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide.
    Penson RT; Joel SP; Roberts M; Gloyne A; Beckwith S; Slevin ML
    Br J Clin Pharmacol; 2002 Apr; 53(4):347-54. PubMed ID: 11966664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphine poisoning in chronic kidney failure. Morphine-6-glucuronide as a pharmacologically active morphine metabolite].
    Dubs A; Wiedemeier P; Caduff B
    Dtsch Med Wochenschr; 1999 Jul; 124(30):896-8. PubMed ID: 10464491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.